ID   TNK1_HUMAN              Reviewed;         666 AA.
AC   Q13470; O95364; Q8IYI4;
DT   15-FEB-2005, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   12-OCT-2022, entry version 179.
DE   RecName: Full=Non-receptor tyrosine-protein kinase TNK1;
DE            EC=2.7.10.2;
DE   AltName: Full=CD38 negative kinase 1;
GN   Name=TNK1 {ECO:0000312|EMBL:AAC99412.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAC50427.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT MET-598, TISSUE
RP   SPECIFICITY, AND CHROMOSOMAL LOCATION.
RC   TISSUE=Umbilical cord blood {ECO:0000312|EMBL:AAC50427.1};
RX   PubMed=8632913;
RA   Hoehn G.T., Stokland T., Amin S., Ramirez M., Hawkins A.L., Griffin C.A.,
RA   Small D., Civin C.I.;
RT   "Tnk1: a novel intracellular tyrosine kinase gene isolated from human
RT   umbilical cord blood CD34+/Lin-/CD38- stem/progenitor cells.";
RL   Oncogene 12:903-913(1996).
RN   [2] {ECO:0000312|EMBL:AAC99412.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT MET-598.
RA   Hoehn G.T., Felschow D.M., Civin C.I.;
RT   "Genomic structure and chromosomal mapping of the human non-receptor
RT   tyrosine kinase gene, Tnk1.";
RL   Submitted (OCT-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000305, ECO:0000312|EMBL:AAH35782.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Ovary {ECO:0000312|EMBL:AAH35782.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4] {ECO:0000305}
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AUTOPHOSPHORYLATION,
RP   AND INTERACTION WITH PLCG1.
RX   PubMed=10873601; DOI=10.1006/bbrc.2000.2887;
RA   Felschow D.M., Civin C.I., Hoehn G.T.;
RT   "Characterization of the tyrosine kinase Tnk1 and its binding with
RT   phospholipase C-gamma1.";
RL   Biochem. Biophys. Res. Commun. 273:294-301(2000).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [6]
RP   FUNCTION.
RX   PubMed=18974114; DOI=10.1158/0008-5472.can-08-1467;
RA   Hoare S., Hoare K., Reinhard M.K., Lee Y.J., Oh S.P., May W.S. Jr.;
RT   "Tnk1/Kos1 knockout mice develop spontaneous tumors.";
RL   Cancer Res. 68:8723-8732(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-60; SER-255; SER-502; THR-514
RP   AND SER-582, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-411 (ISOFORM 2),
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-502 AND SER-519, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-255 AND SER-502,
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-411 (ISOFORM 2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-502 AND THR-514, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-502, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-96 AND SER-502, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   VARIANTS [LARGE SCALE ANALYSIS] ILE-278; LYS-339; LYS-514; CYS-539; CYS-546
RP   AND MET-598.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Involved in negative regulation of cell growth. Has tumor
CC       suppressor properties. Plays a negative regulatory role in the Ras-MAPK
CC       pathway. May function in signaling pathways utilized broadly during
CC       fetal development and more selectively in adult tissues and in cells of
CC       the lymphohematopoietic system. Could specifically be involved in
CC       phospholipid signal transduction. {ECO:0000269|PubMed:10873601,
CC       ECO:0000269|PubMed:18974114}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.2;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};
CC   -!- SUBUNIT: Interacts with the SH3 domain of PLCG1 via its Pro-rich
CC       domain. {ECO:0000269|PubMed:10873601}.
CC   -!- INTERACTION:
CC       Q13470; P31947: SFN; NbExp=2; IntAct=EBI-1383444, EBI-476295;
CC       Q13470-2; Q92567-2: FAM168A; NbExp=3; IntAct=EBI-11018037, EBI-11978259;
CC       Q13470-2; Q13322-4: GRB10; NbExp=3; IntAct=EBI-11018037, EBI-12353035;
CC       Q13470-2; Q8IYX7: SAXO1; NbExp=3; IntAct=EBI-11018037, EBI-3957636;
CC       Q13470-2; O75177-5: SS18L1; NbExp=3; IntAct=EBI-11018037, EBI-12035119;
CC       Q13470-2; P15622-3: ZNF250; NbExp=3; IntAct=EBI-11018037, EBI-10177272;
CC       Q13470-2; Q86UD4: ZNF329; NbExp=3; IntAct=EBI-11018037, EBI-7233259;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10873601}. Membrane
CC       {ECO:0000269|PubMed:10873601}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:10873601}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1 {ECO:0000269|PubMed:8632913};
CC         IsoId=Q13470-1; Sequence=Displayed;
CC       Name=2 {ECO:0000305};
CC         IsoId=Q13470-2; Sequence=VSP_051663;
CC   -!- TISSUE SPECIFICITY: Expressed in all umbilical cord blood, bone marrow
CC       and adult blood cell sub-populations and in several leukemia cell
CC       lines. Highly expressed in fetal blood, brain, lung, liver and kidney.
CC       Detected at lower levels in adult prostate, testis, ovary, small
CC       intestine and colon. Not expressed in adult lung, liver, kidney or
CC       brain. {ECO:0000269|PubMed:10873601, ECO:0000269|PubMed:8632913}.
CC   -!- PTM: Autophosphorylated on tyrosine residues.
CC       {ECO:0000269|PubMed:10873601}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U43408; AAC50427.1; -; mRNA.
DR   EMBL; AF097738; AAC99412.1; -; Genomic_DNA.
DR   EMBL; BC035782; AAH35782.1; -; mRNA.
DR   CCDS; CCDS45602.1; -. [Q13470-2]
DR   CCDS; CCDS58510.1; -. [Q13470-1]
DR   RefSeq; NP_001238831.1; NM_001251902.1. [Q13470-1]
DR   RefSeq; NP_003976.2; NM_003985.4. [Q13470-2]
DR   RefSeq; XP_011522347.1; XM_011524045.2. [Q13470-2]
DR   AlphaFoldDB; Q13470; -.
DR   SMR; Q13470; -.
DR   BioGRID; 114253; 33.
DR   IntAct; Q13470; 40.
DR   MINT; Q13470; -.
DR   STRING; 9606.ENSP00000459799; -.
DR   BindingDB; Q13470; -.
DR   ChEMBL; CHEMBL5334; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; Q13470; -.
DR   GuidetoPHARMACOLOGY; 2245; -.
DR   iPTMnet; Q13470; -.
DR   PhosphoSitePlus; Q13470; -.
DR   BioMuta; TNK1; -.
DR   DMDM; 116242821; -.
DR   EPD; Q13470; -.
DR   jPOST; Q13470; -.
DR   MassIVE; Q13470; -.
DR   MaxQB; Q13470; -.
DR   PaxDb; Q13470; -.
DR   PeptideAtlas; Q13470; -.
DR   PRIDE; Q13470; -.
DR   ProteomicsDB; 59467; -. [Q13470-1]
DR   ProteomicsDB; 59468; -. [Q13470-2]
DR   Antibodypedia; 6049; 367 antibodies from 33 providers.
DR   DNASU; 8711; -.
DR   Ensembl; ENST00000570896.5; ENSP00000458834.1; ENSG00000174292.13. [Q13470-2]
DR   Ensembl; ENST00000576812.5; ENSP00000459799.1; ENSG00000174292.13. [Q13470-1]
DR   Ensembl; ENST00000639010.1; ENSP00000491712.1; ENSG00000283781.1. [Q13470-2]
DR   Ensembl; ENST00000639430.1; ENSP00000491136.1; ENSG00000283781.1. [Q13470-1]
DR   Ensembl; ENST00000688331.1; ENSP00000509611.1; ENSG00000174292.13. [Q13470-2]
DR   GeneID; 8711; -.
DR   KEGG; hsa:8711; -.
DR   MANE-Select; ENST00000688331.1; ENSP00000509611.1; NM_003985.6; NP_003976.2. [Q13470-2]
DR   UCSC; uc002ggi.5; human. [Q13470-1]
DR   CTD; 8711; -.
DR   DisGeNET; 8711; -.
DR   GeneCards; TNK1; -.
DR   HGNC; HGNC:11940; TNK1.
DR   HPA; ENSG00000174292; Low tissue specificity.
DR   MIM; 608076; gene.
DR   neXtProt; NX_Q13470; -.
DR   OpenTargets; ENSG00000174292; -.
DR   PharmGKB; PA36630; -.
DR   VEuPathDB; HostDB:ENSG00000174292; -.
DR   eggNOG; KOG0199; Eukaryota.
DR   GeneTree; ENSGT00940000162159; -.
DR   HOGENOM; CLU_000288_7_39_1; -.
DR   InParanoid; Q13470; -.
DR   OMA; IMMNLEH; -.
DR   OrthoDB; 1008736at2759; -.
DR   PhylomeDB; Q13470; -.
DR   TreeFam; TF316643; -.
DR   PathwayCommons; Q13470; -.
DR   SignaLink; Q13470; -.
DR   BioGRID-ORCS; 8711; 12 hits in 1112 CRISPR screens.
DR   ChiTaRS; TNK1; human.
DR   GenomeRNAi; 8711; -.
DR   Pharos; Q13470; Tchem.
DR   PRO; PR:Q13470; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q13470; protein.
DR   Bgee; ENSG00000174292; Expressed in mucosa of transverse colon and 96 other tissues.
DR   ExpressionAtlas; Q13470; baseline and differential.
DR   Genevisible; Q13470; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IBA:GO_Central.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB.
DR   GO; GO:0005102; F:signaling receptor binding; IBA:GO_Central.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0045087; P:innate immune response; IBA:GO_Central.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IBA:GO_Central.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00326; SH3; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cytoplasm; Kinase; Membrane;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome; SH3 domain;
KW   Transferase; Tyrosine-protein kinase.
FT   CHAIN           1..666
FT                   /note="Non-receptor tyrosine-protein kinase TNK1"
FT                   /id="PRO_0000088173"
FT   DOMAIN          116..377
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          380..445
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   REGION          446..493
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          506..579
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        531..547
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        245
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P12931,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-
FT                   ProRule:PRU10028"
FT   BINDING         122..130
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P12931,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         148
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P12931,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         60
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976"
FT   MOD_RES         96
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         255
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:19369195"
FT   MOD_RES         502
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:18691976, ECO:0007744|PubMed:19369195,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         514
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:20068231"
FT   MOD_RES         519
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         582
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976"
FT   VAR_SEQ         411..415
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_051663"
FT   VARIANT         278
FT                   /note="V -> I (in dbSNP:rs55939858)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041863"
FT   VARIANT         339
FT                   /note="R -> K (in a lung adenocarcinoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041864"
FT   VARIANT         514
FT                   /note="T -> K (in dbSNP:rs55641092)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041865"
FT   VARIANT         539
FT                   /note="R -> C (in dbSNP:rs36046975)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041866"
FT   VARIANT         546
FT                   /note="S -> C (in dbSNP:rs56093628)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041867"
FT   VARIANT         598
FT                   /note="V -> M (in dbSNP:rs6503018)"
FT                   /evidence="ECO:0000269|PubMed:17344846,
FT                   ECO:0000269|PubMed:8632913, ECO:0000269|Ref.2"
FT                   /id="VAR_041868"
FT   CONFLICT        36
FT                   /note="E -> G (in Ref. 1; AAC50427)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        65
FT                   /note="R -> S (in Ref. 1; AAC50427)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        94
FT                   /note="S -> T (in Ref. 1; AAC50427)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        118
FT                   /note="R -> K (in Ref. 2; AAC99412)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        252
FT                   /note="L -> Q (in Ref. 1; AAC50427)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        288
FT                   /note="A -> T (in Ref. 1; AAC50427)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        325
FT                   /note="A -> P (in Ref. 1; AAC50427)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        347..348
FT                   /note="LC -> PS (in Ref. 1; AAC50427)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        391
FT                   /note="V -> A (in Ref. 1; AAC50427)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        424
FT                   /note="G -> D (in Ref. 1; AAC50427)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        443
FT                   /note="A -> T (in Ref. 1; AAC50427)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        561
FT                   /note="K -> E (in Ref. 1; AAC50427)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        604
FT                   /note="G -> W (in Ref. 1; AAC50427)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        622
FT                   /note="V -> A (in Ref. 1; AAC50427)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        635
FT                   /note="H -> L (in Ref. 1; AAC50427)"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         Q13470-2:411
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:19369195"
SQ   SEQUENCE   666 AA;  72468 MW;  AA7FBEF6CC778181 CRC64;
     MLPEAGSLWL LKLLRDIQLA QFYWPILEEL NVTRPEHFDF VKPEDLDGIG MGRPAQRRLS
     EALKRLRSGP KSKNWVYKIL GGFAPEHKEP TLPSDSPRHL PEPEGGLKCL IPEGAVCRGE
     LLGSGCFGVV HRGLWTLPSG KSVPVAVKSL RVGPEGPMGT ELGDFLREVS VMMNLEHPHV
     LRLHGLVLGQ PLQMVMELAP LGSLHARLTA PAPTPPLLVA LLCLFLRQLA GAMAYLGARG
     LVHRDLATRN LLLASPRTIK VADFGLVRPL GGARGRYVMG GPRPIPYAWC APESLRHGAF
     SSASDVWMFG VTLWEMFSGG EEPWAGVPPY LILQRLEDRA RLPRPPLCSR ALYSLALRCW
     APHPADRPSF SHLEGLLQEA GPSEACCVRD VTEPGALRME TGDPITVIEG SSSFHSPDST
     IWKGQNGRTF KVGSFPASAV TLADAGGLPA TRPVHRGTPA RGDQHPGSID GDRKKANLWD
     APPARGQRRN MPLERMKGIS RSLESVLSLG PRPTGGGSSP PEIRQARAVP QGPPGLPPRP
     PLSSSSPQPS QPSRERLPWP KRKPPHNHPM GMPGARKAAA LSGGLLSDPE LQRKIMEVEL
     SVHGVTHQEC QTALGATGGD VVSAIRNLKV DQLFHLSSRS RADCWRILEH YQWDLSAASR
     YVLARP
//
